Ilker Yasin Eyüpoglu
Ilker Yasin Eyüpoglu
Consultant Neurosurgeon
Bestätigte E-Mail-Adresse bei - Startseite
Zitiert von
Zitiert von
Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy
L Brichta, Y Hofmann, E Hahnen, FA Siebzehnrubl, H Raschke, I Blumcke, ...
Human molecular genetics 12 (19), 2481-2489, 2003
Histone deacetylase inhibitors: possible implications for neurodegenerative disorders
E Hahnen, J Hauke, C Tränkle, IY Eyüpoglu, B Wirth, I Blümcke
Expert opinion on investigational drugs 17 (2), 169-184, 2008
Common mutations of β-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region
R Buslei, M Nolde, B Hofmann, S Meissner, IY Eyupoglu, F Siebzehnrübl, ...
Acta neuropathologica 109 (6), 589-597, 2005
Regulation of microglial expression of integrins by poly (ADP-ribose) polymerase-1
O Ullrich, A Diestel, IY Eyüpoglu, R Nitsch
Nature cell biology 3 (12), 1035-1042, 2001
In vitro and ex vivo evaluation of second‐generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy
E Hahnen, IY Eyüpoglu, L Brichta, K Haastert, C Tränkle, FA Siebzehnrübl, ...
Journal of neurochemistry 98 (1), 193-202, 2006
Selenium deficiency increases susceptibility to glutamate‐induced excitotoxicity
NE Savaskan, AU Bräuer, M Kühbacher, IY Eyüpoglu, A Kyriakopoulos, ...
The FASEB Journal 17 (1), 112-114, 2003
Small interfering RNA–mediated xCT silencing in gliomas inhibits neurodegeneration and alleviates brain edema
NE Savaskan, A Heckel, E Hahnen, T Engelhorn, A Doerfler, O Ganslandt, ...
Nature medicine 14 (6), 629-632, 2008
Suberoylanilide hydroxamic acid (SAHA) has potent anti‐glioma properties in vitro, ex vivo and in vivo
IY Eyüpoglu, E Hahnen, R Buslei, FA Siebzehnrübl, NE Savaskan, ...
Journal of neurochemistry 93 (4), 992-999, 2005
Improving the extent of malignant glioma resection by dual intraoperative visualization approach
IY Eyüpoglu, N Hore, NE Savaskan, P Grummich, K Roessler, ...
PloS one 7 (9), e44885, 2012
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomide
W Wick, P Roth, C Hartmann, P Hau, M Nakamura, F Stockhammer, ...
Neuro-oncology 18 (11), 1529-1537, 2016
Surgical resection of malignant gliomas—role in optimizing patient outcome
IY Eyüpoglu, M Buchfelder, NE Savaskan
Nature reviews Neurology 9 (3), 141, 2013
Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone …
J Hauke, M Riessland, S Lunke, IY Eyüpoglu, I Blümcke, A El-Osta, ...
Human molecular genetics 18 (2), 304-317, 2009
Histone deacetylase inhibitors increase neuronal differentiation in adult forebrain precursor cells
FA Siebzehnrubl, R Buslei, IY Eyupoglu, S Seufert, E Hahnen, I Blumcke
Experimental Brain Research 176 (4), 672-678, 2007
Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells
G Tabatabai, O Bähr, R Möhle, IY Eyüpoglu, AM Boehmler, J Wischhusen, ...
Brain 128 (9), 2200-2211, 2005
The sitting position in neurosurgery: indications, complications and results. a single institution experience of 600 cases
O Ganslandt, A Merkel, H Schmitt, A Tzabazis, M Buchfelder, I Eyupoglu, ...
Acta neurochirurgica 155 (10), 1887-1893, 2013
Cellular characterization of the peritumoral edema zone in malignant brain tumors
T Engelhorn, NE Savaskan, MA Schwarz, J Kreutzer, EP Meyer, ...
Cancer science 100 (10), 1856-1862, 2009
Phagocytosis of neuronal or glial debris by microglial cells: upregulation of MHC class II expression and multinuclear giant cell formation in vitro
M Beyer, U Gimsa, IY Eyüpoglu, NP Hailer, R Nitsch
Glia 31 (3), 262-266, 2000
Bone marrow-derived cells expressing green fluorescent protein under the control of the glial fibrillary acidic protein promoter do not differentiate into astrocytes in vitro …
T Wehner, M Böntert, I Eyüpoglu, K Prass, M Prinz, FF Klett, M Heinze, ...
Journal of Neuroscience 23 (12), 5004-5011, 2003
Experimental therapy of malignant gliomas using the inhibitor of histone deacetylase MS-275
IY Eyüpoglu, E Hahnen, C Tränkle, NE Savaskan, FA Siebzehnrübl, ...
Molecular cancer therapeutics 5 (5), 1248-1255, 2006
ATF4 promotes angiogenesis and neuronal cell death and confers ferroptosis in a xCT-dependent manner
D Chen, Z Fan, M Rauh, M Buchfelder, IY Eyupoglu, N Savaskan
Oncogene 36 (40), 5593-5608, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20